Tools
Stock profile

Concentra Group Holdings Parent, Inc. (CON)

CON · Latest close $41.98 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$41.98
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

Concentra Group Holdings Parent, Inc. (CON) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $6.2M sold). Latest close $41.98 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 17, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-6.2M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

First Eagle Investment Management — 1 tracked fund hold CON. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 6 sales ($6.2M). Insider trading

Often held alongside

Acadia Healthcare Company, Inc. (ACHC) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
First Eagle Investment Management0.03%648,059ADDED (+62.1%) Q3 filed Nov 10
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +37.7% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

43.5617.722024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding288 of 8,857 filers
Long-only filers among them288
Change vs 2026 Q1+18 net · 281 entered · 263 exited
Shares reported, all filers111,242,382
Reported value, all filers$2.6B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryServices-Specialty Outpatient Facilities, NEC (SIC 8093)
Revenue · FY2025$2.2B
Net income · FY2025$166.4M
Total assets · FY2025$2.9B
Shares outstanding127,517,736
Market cap (at latest close)$5.4B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 20263,601,334
Share of shares outstanding2.82%
Days to cover2.87

Shares short at recent settlements — Jul 31, 2026: 3.1M · Aug 14, 2026: 2.2M · Aug 31, 2026: 2.8M · Sep 15, 2026: 3.2M · Sep 30, 2026: 3.6M · Oct 15, 2026: 3.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 3K · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 6 sales by 6 insiders ($6.2M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 17, 2026deLorimier John A.See RemarksSell17,444$42.87$747.7KSEC filing
Nov 17, 2026Newton Raymond TannerEVP & Chief Financial OfficerSell2,843$42.93$122.0KSEC filing
Nov 16, 2026Newton William KeithSell68,232$43.13$2.9MSEC filing
Nov 16, 2026Devasia Thomas A.See RemarksSell18,194$42.92$781.0KSEC filing
Nov 12, 2026Gilbert Greg M.See RemarksSell18,194$42.90$780.5KSEC filing
Nov 12, 2026Conser Jonathan P.See RemarksSell18,194$42.99$782.2KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 3, 2026ORTENZIO ROBERT ADirector130,000$4.1MAug 3, 2026SEC filing
Jul 1, 2026ORTENZIO ROBERT ADirector389,940$15.9MJul 1, 2026SEC filing
Jun 30, 2026ORTENZIO ROBERT ADirector944$27.8KJun 30, 2026SEC filing
Jun 29, 2026ORTENZIO ROBERT ADirector5,589$166.8KJun 29, 2026SEC filing
Jun 26, 2026ORTENZIO ROBERT ADirector53,527$1.6MJun 26, 2026SEC filing
Jun 26, 2026ORTENZIO ROBERT ADirector53,527$1.6MJun 26, 2026SEC filing
Jun 1, 2026ORTENZIO ROBERT AChairman130,000$3.2MJun 1, 2026SEC filing
May 8, 2026ORTENZIO ROBERT AChairman130,000$3.2MMay 8, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Sep 1, 2026SCHEDULE 13D/A+24.5% (close Sep 2, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Sep 2, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Sep 1, 2026Robert A. OrtenzioSC 13D/A6,648,2225.2%Sep 1, 2026SEC filing
Aug 24, 2026Robert A. OrtenzioSC 13D/A6,748,2225.3%Aug 21, 2026SEC filing
Jul 27, 2026BlackRock, Inc.SC 13G/A17,569,59013.7%Jun 30, 2026SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G6,837,1485.3%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 17, 2026T. Rowe Price Associates, Inc.SC 13G/A16,843,42513.1%Dec 31, 2025SEC filing
Nov 26, 2025ORTENZIO ROBERT ASC 13D/A8,168,2226.4%Nov 25, 2025SEC filing
Nov 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A6,267,9494.9%Sep 30, 2025SEC filing
Nov 14, 2025T. Rowe Price Associates, Inc.SC 13G/A17,166,75313.4%Sep 30, 2025SEC filing
Jul 7, 2025The Vanguard GroupSC 13G/A13,177,36310.3%Jun 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Services-Specialty Outpatient Facilities, NEC (SIC 8093). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.54 · Operating cash flow: $279.4M · Net income: $166.4M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Also held by the tracked funds that hold CON — ranked by lift, the co-holding pattern described in Methodology: Acadia Healthcare Company, Inc. (ACHC) · HCA Healthcare, Inc. (HCA) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · Brookdale Senior Living Inc. (BKD) · LABCORP HOLDINGS INC. (LH) · RadNet, Inc. (RDNT) · BrightSpring Health Services, Inc. (BTSG).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 10, 20261.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and ExhibitsSEC filing
Nov 9, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing
Nov 5, 20262.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Acadia Healthcare Company, Inc. (ACHC) · Track Record: how the signals scored · Practice timing on CON

One email a week: the week’s new filings and research. Subscribe free

← COMP  ·  COO →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.